WallStreetZenWallStreetZen

NASDAQ: IRD
Opus Genetics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Opus Genetics revenue was $14.63M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $3.1M, up 6.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IRD annual revenue was $11.0M, with -42.3% growth year-over-year.

IRD past revenue growth

How has IRD's revenue growth performed historically?

Company
74.6%
Industry
304.68%
Market
21.11%
IRD's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IRD's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IRD's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IRD revenue history

Current Revenue
$14.6M
Current Earnings
-$68.2M
Current Profit Margin
-466.1%

Be the first to know when IRD announces revenue.

IRD Revenue History By Year

IRD Yearly RevenueIRD RevenueIRD ChangeIRD Revenue Growth
2024-12-31$10.99M-$8.06M-42.30%
2023-12-31$19.05M-$20.80M-52.20%
2022-12-31$39.85M$39.26M+6,665.70%
2021-12-31$589.00kN/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A
2012-12-31$0.00N/AN/A
2011-12-31$0.00N/AN/A
2010-12-31$0.00N/AN/A
2009-12-31$0.00-$75.00k-100.00%
2008-12-31$75.00k$0.000.00%
2007-12-31$75.00k$0.000.00%
2006-12-31$75.00k$0.000.00%
2005-12-31$75.00k$0.000.00%
2004-12-31$75.00kN/AN/A

1 of 2

Opus Genetics Revenue FAQ

What was IRD's revenue last quarter?

On Invalid Date, Opus Genetics (NASDAQ: IRD) reported Q3 2025 revenue of $3.08 million up 20.38% year over year. In the same quarter last year, Opus Genetics's revenue was $3.87 million.

What was Opus Genetics's revenue in 2024?

Opus Genetics's annual revenue for the twelve months ending Dec 31, 2024 was $10.99 million, a 42.3% decrease year over year.

How much does Opus Genetics make in a day?

Based on Opus Genetics annual revenue for the past five years, IRD makes an average of $38,619.18 per day.

What was Opus Genetics's annual revenue growth in the past year?

As of Q4 2025, Opus Genetics's revenue has grown 74.6% year over year. This is 230.08 percentage points lower than the US Biotechnology industry revenue growth rate of 304.68%. Opus Genetics's revenue in the past year totaled $14.63 million.

How much does Opus Genetics make in a year?

Opus Genetics's revenue by year for the past five years is:
  • Opus Genetics's revenue for the twelve months ending Dec 31, 2024 was $10.99 million, a 42.3% decrease year over year.
  • Opus Genetics's annual revenue for Dec 31, 2023 was $19.05 million, a 52.2% decrease from 2022.
  • Opus Genetics's annual revenue for 2022 was $39.85 million, a 6,665.7% increase from 2021.
  • Opus Genetics's annual revenue for 2021 was $589.00 thousand, a Infinity% increase from 2020.
  • Opus Genetics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.